The medtech company Synthetic MR increased revenue and reduced the loss in the fourth quarter. The company previously released preliminary figures. Revenue rose 42.9 percent to SEK 18 million (12.6).Combinostics increased its annual recurring revenue, ARR, by 2 percent measured as a quarterly rate to SEK 11.7 million. "The third quarter was about clarifying our commercial priorities and strengthening the company'sfoundation. In the fourth quarter we see signs that we are on the right track," says CEO Lena Åredal. The operating result was -SEK 5.3 million (-7.5). Profit before tax was -SEK 5.9 million (-5.2). Profit after tax was -SEK 6 million (-5.3). Earnings per share amounted to -SEK 0.12 (-0.14). No ordinary dividend is proposed (0). Cash flow from operating activities amounted to -SEK 4.3 million (-2.8)."The year has laid the foundation for a more focused, cost-conscious and commercially drivenSyntheticMR. We have a clear plan to reach profitability without additional capital injections. The planis based on sharper commercial execution, continued growth in recurring revenue and strictcost discipline. A prioritized focus is to return to growth in the US," states Åredal. She continues."The focus going forward is about prioritizing time and money and increasing efficiency. We need to greatlyimprove accountability in decisions, execution and follow-up across the entire organization." She sees good long-term growth opportunities. "New disease-modifying Alzheimer treatments are changing healthcare workflows and increasing the need for regular, standardized MR follow-up – especially for ARIA monitoring. This is a structural market change where cNeuro is well positioned. Demand is growing fastest in the US and Japan, and Europe follows gradually. This creates good long-term growth prospects."Synthetic MR, MSEKQ4-2025Q4-2024ChangeNet sales1812.642.9%Operating result-5.3-7.5Profit before tax-5.9-5.2Net profit-6-5.3Earnings per share, SEK-0.12-0.14Cash flow from operating activities-4.3-2.8Ordinary annual dividend per share, SEK00